"Borrelia burgdorferi is the recognized infective agent of Lyme disease and DNA sequencing can offer reliable diagnosis of Lyme disease at its early phase of infection for timely appropriate treatment of the patients to avoid tissue damages, stated Dr. Lee and his colleagues in a 2010 publication
(http://www.ncbi.nlm.nih.gov/
Milford Medical Laboratory, Inc. will be positioned to offer these DNA sequencing-based molecular diagnostic tests to the patients and physicians."
